Annual Accounts Receivable
N/A
March 1, 2024
Summary
- GRCE annual accounts receivable is not available.
Performance
GRCE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 1, 2024
Summary
- GRCE quarterly accounts receivable is not available.
Performance
GRCE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GRCE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GRCE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Grace Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $778.00 K(-9.4%) |
| Sep 2022 | - | $859.00 K(-10.9%) |
| Jun 2022 | - | $964.00 K(+305.0%) |
| Dec 2021 | - | $238.00 K(-70.7%) |
| Sep 2021 | - | $813.00 K(+81.5%) |
| Jun 2021 | - | $448.00 K(-27.6%) |
| Dec 2020 | - | $619.00 K(-1.0%) |
| Sep 2020 | - | $625.00 K(+26.3%) |
| Jun 2020 | - | $495.00 K(-58.4%) |
| Dec 2019 | - | $1.19 M(+24.0%) |
| Sep 2019 | - | $960.90 K(-31.7%) |
| Jun 2019 | - | $1.41 M(+1.8%) |
| Dec 2018 | - | $1.38 M(+52.3%) |
| Sep 2018 | - | $907.10 K(+93.0%) |
| Jun 2018 | - | $469.90 K(+56.3%) |
| Dec 2017 | - | $300.60 K(+53.4%) |
| Sep 2017 | - | $195.90 K(+131.6%) |
| Jun 2017 | - | $84.60 K(-22.8%) |
| Nov 2016 | - | $109.60 K(+136.2%) |
| Aug 2016 | - | $46.40 K(-56.8%) |
| May 2016 | - | $107.40 K(-20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2015 | - | $134.60 K(-8.6%) |
| Aug 2015 | - | $147.20 K(-32.8%) |
| May 2015 | - | $219.20 K(+9.5%) |
| Feb 2015 | $200.10 K(-43.6%) | $200.10 K(-24.4%) |
| Nov 2014 | - | $264.70 K(-55.1%) |
| Aug 2014 | - | $588.90 K(-10.5%) |
| May 2014 | - | $657.90 K(+85.3%) |
| Feb 2014 | $355.10 K(+107.2%) | $355.10 K(-20.2%) |
| Nov 2013 | - | $445.10 K(+47.0%) |
| Aug 2013 | - | $302.80 K(-48.3%) |
| May 2013 | - | $585.50 K(+241.6%) |
| Feb 2013 | $171.40 K(+3016.4%) | $171.40 K(-84.8%) |
| Nov 2012 | - | $1.13 M(+59.8%) |
| Aug 2012 | - | $706.10 K(+20.1%) |
| May 2012 | - | $587.90 K(>+9900.0%) |
| Feb 2012 | $5500.00(-89.8%) | $5500.00(-98.9%) |
| Nov 2011 | - | $482.30 K(-3.0%) |
| Aug 2011 | - | $497.30 K(+195.1%) |
| May 2011 | - | $168.50 K(+211.5%) |
| Feb 2011 | $54.10 K(+22.7%) | $54.10 K(+22.7%) |
| Feb 2010 | $44.10 K | $44.10 K |
FAQ
- What is the all time high annual accounts receivable for Grace Therapeutics?
- What is the all time high quarterly accounts receivable for Grace Therapeutics?
What is the all time high annual accounts receivable for Grace Therapeutics?
Grace Therapeutics all-time high annual accounts receivable is $355.10 K
What is the all time high quarterly accounts receivable for Grace Therapeutics?
Grace Therapeutics all-time high quarterly accounts receivable is $1.41 M